+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-tumor Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 110 Pages
  • March 2024
  • Region: Global
  • Prof Research
  • ID: 5950742

Quick Summary:

In the rapidly evolving landscape of oncology treatments, the Anti-tumor Injection market stands out as a critical area for ongoing innovation and strategic investment. Our comprehensive market research report offers an incisive look into this dynamic industry, delivering nuanced insights into the growth trajectories and shifts that have been shaping it.

Executives requiring a keen analysis of the Anti-tumor Injection space will find this report indispensable for informed decision-making. It meticulously outlines the supply and demand dynamics across key regions, along with key player performances, pricing trends, and market segmentation by application and type. Insights extend from regional granularity to the competitive landscape, featuring a thorough SWOT analysis and market share data for leading and emerging players alike. With the inclusion of strategic intelligence on a range of cancers treated by these injections, this report serves as the blueprint for driving growth and refining competitive strategies in your enterprise.

This report describes the global market size of Anti-tumor Injection from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Anti-tumor Injection as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Breast Cancer
  • Stomach Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Testicular Cancer
  • Cervical Cancer
  • Endometrial Cancer
  • Prostate Cancer
  • Bladder Cancer
  • Others

Types Segment:

  • Docetaxel Injection
  • Paclitaxel Injection
  • Bevacizumab Injection
  • Adalimumab Injection
  • Rituximab Injection
  • Others

Companies Covered:

  • Roche
  • Bayer
  • Novartis
  • Pfizer
  • Amgen
  • Mabxience
  • Luoxin Pharmaceutical
  • Qilu Pharmaceutical
  • Zhejiang Borui Biopharmaceutical
  • Fuxing Medicine
  • Yuekang Pharmaceutical
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-Tumor Injection Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-Tumor Injection Market in North America (2019-2029)
8.1 Anti-Tumor Injection Market Size
8.2 Anti-Tumor Injection Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Tumor Injection Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-Tumor Injection Market in South America (2019-2029)
9.1 Anti-Tumor Injection Market Size
9.2 Anti-Tumor Injection Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Tumor Injection Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anti-Tumor Injection Market in Asia & Pacific (2019-2029)
10.1 Anti-Tumor Injection Market Size
10.2 Anti-Tumor Injection Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Tumor Injection Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-Tumor Injection Market in Europe (2019-2029)
11.1 Anti-Tumor Injection Market Size
11.2 Anti-Tumor Injection Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Tumor Injection Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-Tumor Injection Market in MEA (2019-2029)
12.1 Anti-Tumor Injection Market Size
12.2 Anti-Tumor Injection Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Tumor Injection Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anti-Tumor Injection Market (2019-2024)
13.1 Anti-Tumor Injection Market Size
13.2 Anti-Tumor Injection Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Tumor Injection Market Size by Type
Chapter 14 Global Anti-Tumor Injection Market Forecast (2024-2029)
14.1 Anti-Tumor Injection Market Size Forecast
14.2 Anti-Tumor Injection Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Tumor Injection Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Anti-tumor Injection Information
15.1.3 SWOT Analysis of Roche
215.1.4 Roche Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.2 Bayer
15.2.1 Company Profile
15.2.2 Main Business and Anti-tumor Injection Information
15.2.3 SWOT Analysis of Bayer
215.2.4 Bayer Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and Anti-tumor Injection Information
15.3.3 SWOT Analysis of Novartis
215.3.4 Novartis Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.4 Pfizer
15.4.1 Company Profile
15.4.2 Main Business and Anti-tumor Injection Information
15.4.3 SWOT Analysis of Pfizer
215.4.4 Pfizer Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.5 Amgen
15.5.1 Company Profile
15.5.2 Main Business and Anti-tumor Injection Information
15.5.3 SWOT Analysis of Amgen
215.5.4 Amgen Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.6 Mabxience
15.6.1 Company Profile
15.6.2 Main Business and Anti-tumor Injection Information
15.6.3 SWOT Analysis of Mabxience
215.6.4 Mabxience Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.7 Luoxin Pharmaceutical
15.7.1 Company Profile
15.7.2 Main Business and Anti-tumor Injection Information
15.7.3 SWOT Analysis of Luoxin Pharmaceutical
215.7.4 Luoxin Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.8 Qilu Pharmaceutical
15.8.1 Company Profile
15.8.2 Main Business and Anti-tumor Injection Information
15.8.3 SWOT Analysis of Qilu Pharmaceutical
215.8.4 Qilu Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.9 Zhejiang Borui Biopharmaceutical
15.9.1 Company Profile
15.9.2 Main Business and Anti-tumor Injection Information
15.9.3 SWOT Analysis of Zhejiang Borui Biopharmaceutical
215.9.4 Zhejiang Borui Biopharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.10 Fuxing Medicine
15.10.1 Company Profile
15.10.2 Main Business and Anti-tumor Injection Information
15.10.3 SWOT Analysis of Fuxing Medicine
215.10.4 Fuxing Medicine Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
15.11 Yuekang Pharmaceutical
15.11.1 Company Profile
15.11.2 Main Business and Anti-tumor Injection Information
15.11.3 SWOT Analysis of Yuekang Pharmaceutical
215.11.4 Yuekang Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-Tumor Injection Report
Table Data Sources of Anti-Tumor Injection Report
Table Major Assumptions of Anti-Tumor Injection Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Tumor Injection Picture
Table Anti-Tumor Injection Classification
Table Anti-Tumor Injection Applications
Table Drivers of Anti-Tumor Injection Market
Table Restraints of Anti-Tumor Injection Market
Table Opportunities of Anti-Tumor Injection Market
Table Threats of Anti-Tumor Injection Market
Table COVID-19 Impact For Anti-Tumor Injection Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Tumor Injection
Table Cost Structure Analysis of Anti-Tumor Injection
Table Key End Users
Table Latest News of Anti-Tumor Injection Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Tumor Injection Market
Table Policy of Anti-Tumor Injection Market
Table 2019-2029 North America Anti-Tumor Injection Market Size
Figure 2019-2029 North America Anti-Tumor Injection Market Size and CAGR
Table 2019-2029 North America Anti-Tumor Injection Market Size by Application
Table 2019-2024 North America Anti-Tumor Injection Key Players Revenue
Table 2019-2024 North America Anti-Tumor Injection Key Players Market Share
Table 2019-2029 North America Anti-Tumor Injection Market Size by Type
Table 2019-2029 United States Anti-Tumor Injection Market Size
Table 2019-2029 Canada Anti-Tumor Injection Market Size
Table 2019-2029 Mexico Anti-Tumor Injection Market Size
Table 2019-2029 South America Anti-Tumor Injection Market Size
Figure 2019-2029 South America Anti-Tumor Injection Market Size and CAGR
Table 2019-2029 South America Anti-Tumor Injection Market Size by Application
Table 2019-2024 South America Anti-Tumor Injection Key Players Revenue
Table 2019-2024 South America Anti-Tumor Injection Key Players Market Share
Table 2019-2029 South America Anti-Tumor Injection Market Size by Type
Table 2019-2029 Brazil Anti-Tumor Injection Market Size
Table 2019-2029 Argentina Anti-Tumor Injection Market Size
Table 2019-2029 Chile Anti-Tumor Injection Market Size
Table 2019-2029 Peru Anti-Tumor Injection Market Size
Table 2019-2029 Asia & Pacific Anti-Tumor Injection Market Size
Figure 2019-2029 Asia & Pacific Anti-Tumor Injection Market Size and CAGR
Table 2019-2029 Asia & Pacific Anti-Tumor Injection Market Size by Application
Table 2019-2024 Asia & Pacific Anti-Tumor Injection Key Players Revenue
Table 2019-2024 Asia & Pacific Anti-Tumor Injection Key Players Market Share
Table 2019-2029 Asia & Pacific Anti-Tumor Injection Market Size by Type
Table 2019-2029 China Anti-Tumor Injection Market Size
Table 2019-2029 India Anti-Tumor Injection Market Size
Table 2019-2029 Japan Anti-Tumor Injection Market Size
Table 2019-2029 South Korea Anti-Tumor Injection Market Size
Table 2019-2029 Southeast Asia Anti-Tumor Injection Market Size
Table 2019-2029 Australia Anti-Tumor Injection Market Size
Table 2019-2029 Europe Anti-Tumor Injection Market Size
Figure 2019-2029 Europe Anti-Tumor Injection Market Size and CAGR
Table 2019-2029 Europe Anti-Tumor Injection Market Size by Application
Table 2019-2024 Europe Anti-Tumor Injection Key Players Revenue
Table 2019-2024 Europe Anti-Tumor Injection Key Players Market Share
Table 2019-2029 Europe Anti-Tumor Injection Market Size by Type
Table 2019-2029 Germany Anti-Tumor Injection Market Size
Table 2019-2029 France Anti-Tumor Injection Market Size
Table 2019-2029 United Kingdom Anti-Tumor Injection Market Size
Table 2019-2029 Italy Anti-Tumor Injection Market Size
Table 2019-2029 Spain Anti-Tumor Injection Market Size
Table 2019-2029 Belgium Anti-Tumor Injection Market Size
Table 2019-2029 Netherlands Anti-Tumor Injection Market Size
Table 2019-2029 Austria Anti-Tumor Injection Market Size
Table 2019-2029 Poland Anti-Tumor Injection Market Size
Table 2019-2029 Russia Anti-Tumor Injection Market Size
Table 2019-2029 MEA Anti-Tumor Injection Market Size
Figure 2019-2029 MEA Anti-Tumor Injection Market Size and CAGR
Table 2019-2029 MEA Anti-Tumor Injection Market Size by Application
Table 2019-2024 MEA Anti-Tumor Injection Key Players Revenue
Table 2019-2024 MEA Anti-Tumor Injection Key Players Market Share
Table 2019-2029 MEA Anti-Tumor Injection Market Size by Type
Table 2019-2029 Egypt Anti-Tumor Injection Market Size
Table 2019-2029 Israel Anti-Tumor Injection Market Size
Table 2019-2029 South Africa Anti-Tumor Injection Market Size
Table 2019-2029 Gulf Cooperation Council Countries Anti-Tumor Injection Market Size
Table 2019-2029 Turkey Anti-Tumor Injection Market Size
Table 2019-2024 Global Anti-Tumor Injection Market Size by Region
Table 2019-2024 Global Anti-Tumor Injection Market Size Share by Region
Table 2019-2024 Global Anti-Tumor Injection Market Size by Application
Table 2019-2024 Global Anti-Tumor Injection Market Share by Application
Table 2019-2024 Global Anti-Tumor Injection Key Vendors Revenue
Figure 2019-2024 Global Anti-Tumor Injection Market Size and Growth Rate
Table 2019-2024 Global Anti-Tumor Injection Key Vendors Market Share
Table 2019-2024 Global Anti-Tumor Injection Market Size by Type
Table 2019-2024 Global Anti-Tumor Injection Market Share by Type
Table 2024-2029 Global Anti-Tumor Injection Market Size by Region
Table 2024-2029 Global Anti-Tumor Injection Market Size Share by Region
Table 2024-2029 Global Anti-Tumor Injection Market Size by Application
Table 2024-2029 Global Anti-Tumor Injection Market Share by Application
Table 2024-2029 Global Anti-Tumor Injection Key Vendors Revenue
Figure 2024-2029 Global Anti-Tumor Injection Market Size and Growth Rate
Table 2024-2029 Global Anti-Tumor Injection Key Vendors Market Share
Table 2024-2029 Global Anti-Tumor Injection Market Size by Type
Table 2024-2029 Anti-Tumor Injection Global Market Share by Type

Companies Mentioned

  • Roche
  • Bayer
  • Novartis
  • Pfizer
  • Amgen
  • Mabxience
  • Luoxin Pharmaceutical
  • Qilu Pharmaceutical
  • Zhejiang Borui Biopharmaceutical
  • Fuxing Medicine
  • Yuekang Pharmaceutical
  • Yuheng Pharmaceutical
  • Hengrui Medicine
  • Huiyu Pharmaceuti

Methodology

Loading
LOADING...